FDA gives approval to two Parkinson's drugs

PITTSBURGH The Food and Drug Administration has approved Mylan’s carbidopa and levodopa orally disintegrating tablets, Mylan announced Monday.

The tablets are approved for treating idiopathic Parkinson’s disease and are the generic version of Schwarz Pharma’s Parcopa ODT. The branded drug had sales of about $7.4 million over the 12 months ending June 30, according to IMS Health.

Mylan’s product will be the first generic version of Parcopa to reach the market, giving Mylan 180 days of market exclusivity.